Master Attention-Deficit Hyperactivity Disorder (ADHD) Interventions with Picmonic for Physician Assistant

Central nervous system stimulants have a paradoxical calming effect in patients with ADHD. Examples of these medications include amphetamine and dextroamphetamine (Adderall), methylphenidate (Ritalin), and lisdexamfetamine (Vyvanse).

Amphetamine and dextroamphetamine (Adderall) are effective in reducing symptoms in patients with ADHD.

Stimulant medications such as methylphenidate (Ritalin) is also approved for management of symptoms in patients with ADHD.

Bupropion (Wellbutrin), an anti-depressant medication, has been used off-label and shown to reduce symptoms of ADHD. In regard to ADHD therapy, the mechanism of action remains unclear.

Atomoxetine (Strattera) is a non-stimulant medication approved for use in patients with ADHD. This medication increases the amount of norepinephrine in the brain, thereby improving memory and reducing impulsiveness.

Guanfacine (Intuniv) is also a non-stimulant medication approved for use in patients with ADHD. This medication also affects receptors in the brain, though the exact mechanism in treating ADHD is unknown. Guanfacine (Intuniv) helps to reduce distractibility and to improve attention and impulse control.

Non-pharmacological methods should also be used to manage disruptive behavior in patients with ADHD. Cognitive behavioral therapy, and skills coaching are a few treatment options available that will encourage academic and social success in these patients.

Because patients with ADHD have short attention spans and are easily distracted, simple instructions should be used when giving directions. Simple instructions may improve the individual’s ability to complete a task.